Phase 1 Primary Biliary Cholangitis Trial, Completed (NCT01879735)

Phase 1 Primary Biliary Cholangitis Trial, Completed NCT01879735 Sponsor: University of Aarhus Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT01879735 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Trial results

AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

According to the results reported on ClinicalTrials.gov, this trial involved 22 people in total — 6 in a group receiving an ICG (indocyanine green) infusion, and 16 in a group receiving a substance called 11C-CSar delivered by a bolus (a single quick dose) followed by a constant drip. The trial was measuring whether researchers could use these methods to track and measure how the liver processes and transports certain substances, using specialised imaging techniques. The reported data shows one primary outcome was measured: the percentage of participants in each group for whom the researchers were able to successfully measure liver transport activity. According to the results reported on ClinicalTrials.gov, this figure was 100% in both groups — meaning that for every participant, the researchers reported being able to obtain a measurable result using the method being tested. No secondary outcome data appears to have been reported in the submitted results. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.

View full results on ClinicalTrials.gov ↗ · Read the linked publication on PubMed (PMID 28249726) ↗

These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a liver condition that affects the flow of bile (a cholestatic disorder)
Healthy individuals with no such condition may also be able to take part

Who may not be able to join:

People who weigh more than 110 kg (about 243 pounds), as this can make a medical procedure used in the trial more difficult
People who have diabetes
Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I found the following past clinical trial relevant to my condition, and wanted to raise it with you. It is no longer recruiting, but I wanted to ask whether similar active trials exist, or whether its results are relevant to my care:

Trial: NCT01879735

Sponsor: University of Aarhus

Phase: Phase 1

Status: Completed

Condition: Primary Biliary Cholangitis

More information: https://clinicaltrials.gov/study/NCT01879735

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a liver condition that affects the flow of bile (a cholestatic disorder)
Healthy individuals with no such condition may also be able to take part

Who may not be able to join:

People who weigh more than 110 kg (about 243 pounds), as this can make a medical procedure used in the trial more difficult
People who have diabetes
Women who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Completed

Phase

Phase 1

Sponsor

University of Aarhus

Registry

ClinicalTrials.gov

Start date

1 June 2013

Est. completion

1 September 2014

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Percentage of Participants in Whom we Could Quantify Hepatic Transport of 11C-CSar

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov